ZEOX (Zeo ScientifiX) EPS (Basic): $-0.58 (TTM As of Apr. 2026)


ZEOX Zeo ScientifiX Inc ZEOX
50 GF Score
Price $1.75
GF Value $2.67
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Zeo ScientifiX EPS (Basic)?

Zeo ScientifiX ZEOX +2.94% 50 EPS (Basic) is $-0.58 as of Apr. 2026. GuruFocus rates ZEOX with a GF Score™ of 50/100 and a GF Value™ of $2.67 (Possible Value Trap). The stock has 4 warning signs investors should review.

Zeo ScientifiX's basic earnings per share (Basic EPS) for the three months ended in Apr. 2026 was $-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.58.

Zeo ScientifiX's EPS (Diluted) for the three months ended in Apr. 2026 was $-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.58.

Zeo ScientifiX's EPS without NRI for the three months ended in Apr. 2026 was $-0.07. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Apr. 2026 was -0.63.

During the past 3 years, the average EPS without NRI Growth Rate was 18.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 26.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 13.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Zeo ScientifiX's highest 3-Year average EPS without NRI Growth Rate was 37.20% per year. The lowest was -256.90% per year. And the median was 3.10% per year.

Zeo ScientifiX  (OTCPK:ZEOX) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Zeo ScientifiX EPS (Basic) Related Terms

Zeo ScientifiX EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Zeo ScientifiX's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zeo ScientifiX EPS (Basic) Chart

Zeo ScientifiX Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.00 -1.56 -0.99 -0.74 -0.86

Zeo ScientifiX Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.22 -0.32 -0.12 -0.12 -0.02
ZEOX
50GF Score
Zeo ScientifiX Inc ZEOX
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zeo ScientifiX EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Zeo ScientifiX's Basic EPS for the fiscal year that ended in Oct. 2025 is calculated as

Basic EPS (A: Oct. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-5.521-0)/6.410
=-0.86

Zeo ScientifiX's Basic EPS for the quarter that ended in Apr. 2026 is calculated as

Basic EPS (Q: Apr. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.145-0)/7.757
=-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.58 mean?
Zeo ScientifiX (ZEOX) has a EPS (Basic) of $-0.58 as of Apr. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Zeo ScientifiX and its competitors.
Is Zeo ScientifiX's EPS (Basic) too high?
Zeo ScientifiX's current EPS (Basic) is $-0.58. Overall, Zeo ScientifiX has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's EPS (Basic) compare to LNAI and GDTC?
Zeo ScientifiX's EPS (Basic) of $-0.58 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Zeo ScientifiX and its competitors. Zeo ScientifiX's current EPS (Basic) is $-0.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Possible Value Trap. The stock's GF Value™ is $2.67, compared to a current price of $1.75 — trading 34.5% below its estimated fair value. The current EPS (Basic) is $-0.58. Zeo ScientifiX's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current EPS (Basic) is $-0.58 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zeo ScientifiX (ZEOX) Overvalued in 2026?

Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued. The current stock price of $1.75 is trading 34.5% below its estimated GF Value™ of $2.67. GuruFocus considers Zeo ScientifiX to be Possible Value Trap.

Key valuation signals for ZEOX:

  • EPS (Basic): $-0.58
  • GF Value™: $2.67 vs. price of $1.75 (34.5% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zeo ScientifiX Business Description

Address 3321 College Avenue, Suite 246, Davie, FL, USA, 33314
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
50GF Score

Get the complete analysis for ZEOX

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.75
Price
$2.67
GF Value